The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome.
Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen
Baylor will use the arrays for studying genomic imprinting and its role in developmental diseases.
Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.
What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.
A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.
Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.
In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.